| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 693248 | Null | 0.0135714101922724 | 0.14886981 |
| NSC 709974 | Null | 0.0135714101922724 | 0.40388103 |
| NSC 716002 | Null | 0.0135714101922724 | 0.39290753 |
| NSC 717468 | Null | 0.0135714101922724 | 0.3396393 |
| NSC 726089 | 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate | 0.0135714101922724 | 0.14661688 |
| NSC 734287 | 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0135714101922724 | 0.028056181 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0135714101922724 | 0.35696598 |
| NSC 753456 | 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole | 0.0135714101922724 | 0.31836439 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0139796580235792 | 0.22128311 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0139796580235792 | 0.27660311 |